Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950144-06-001974
Filing Date
2006-03-08
Accepted
2006-03-08 17:06:30
Documents
6
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 KING PHARMACEUTICALS, INC. - FORM 10-K/A g99351a1e10vkza.htm 10-K/A 25674
2 EX-23.1 CONSENT OF PRICEWATERHOUSECOOPERS LLP g99351a1exv23w1.txt EX-23.1 1012
3 EX-31.1 SECTION 302 CERTIFICATION OF THE CEO g99351a1exv31w1.txt EX-31.1 4238
4 EX-31.2 SECTION 302 CERTIFICATION OF THE CFO g99351a1exv31w2.txt EX-31.2 4235
5 EX-32.1 SECTION 906 CERTIFICATION OF THE CEO g99351a1exv32w1.txt EX-32.1 1430
6 EX-32.2 SECTION 906 CERTIFICATION OF THE CFO g99351a1exv32w2.txt EX-32.2 1427
  Complete submission text file 0000950144-06-001974.txt   39387
Mailing Address 501 FIFTH ST BRISTOL TN 37620
Business Address 501 FIFTH ST BRISTOL TN 37620 4239898000
KING PHARMACEUTICALS INC (Filer) CIK: 0001047699 (see all company filings)

EIN.: 541684963 | State of Incorp.: TN | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-15875 | Film No.: 06673770
SIC: 2834 Pharmaceutical Preparations